Portfolio Health Check
| Score Your rating score is 3.43 / 5.0 | Breakdown Strong Buy: 0 stocks Buy: 2 stocks Hold: 16 stocks Sell: 0 stocks Strong Sell: 0 stocks |
Yesterday's Performance
| Top Gainers | Top Losers |
| PM: +1.76% | ABT: -1.37% |
| XOM: +1.25% | JNJ: -0.97% |
| COP: +1.08% | T: -0.79% |
Breaking News
FEATURED: Go Premium for $4.95 for your first 30 days
Get the bull and bear perspective on 1000s of stocks with Seeking Alpha's diverse pool of contributors and community debate. Join Premium for only $4.95 for your first 30 days.
Analysis
| AT&T: Why We Are Still Buying Matthew Smith • T |
| AT&T: Not Cheap Enough JR Research • T |
Related Analysis
| 12 Dividend Blue-Chip Bargains That Will Leave You Swimming In Cash Dividend Sensei • MO |
| Diversity And Inclusion - An Investor's Handbook AllianceBernstein (AB) • JNJ |
| Dollar Cost Averaging: Delivering Above-Average Portfolio Returns Financial Engineering • MSFT |
| SCHH: Buy The Correction, 3 Must-Have REITs To Own Yannick Frey • WMT |
| I Smell Deep Value At International Flavors & Fragrances More Ideas Than Money • WMT |
| Tracking John Rogers' Ariel Investments Portfolio - Q4 2022 Update John Vincent • MSFT • PM |
| Super Micro Computer: Still Room To Run? Ironside Research • MSFT |
| Berkshire Grey: This Go-Private Transaction Makes Sense Daniel Jones • WMT |
| Selecting Dividend Aristocrats Using SCHD Methodology - Mounting A Comeback Dividend Yield Theorist • MCD • KO • PG |
If you believe this has been sent to you in error, please safely unsubscribe.
